https://youtu.be/MLu1npKFqZg Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q4 FY22 Earnings Concall Management Update: DIVISLAB said it reached milestone revenue for FY22
Divi's Laboratories Ltd
-(DIVISLAB)
XNSE:DIVISLAB, XBOM:DIVISLAB
Divi’s Laboratories Ltd Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=E7EoiAKzMn0 Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q3 FY22 Earnings Concall Management Update: The company capitalized INR196 crores in 3Q22 and
Divi’s Laboratories Ltd (DIVISLAB) Q3 FY22 Earnings Conference Call Transcript
Divi's Laboratories Ltd (NSE: DIVISLAB) Q3 FY22 Earnings Concall dated Feb. 11, 2022 Corporate Participants: M. Satish Choudhury -- Company Secretary and Compliance Officer
Infographic: All you need to know about Divis Labs Q3 performance
Divi's Laboratories(NSE: DIVISLABS) reported its second-quarter 2022 earnings release The company had net consolidated revenue of ₹2,006 crores with a growth of
Divi’s Laboratories Ltd (DIVISLAB) Q2 FY22 Earnings Concall Transcript
Divi's Laboratories Ltd (NSE:DIVISLAB) Q2 FY22 Earnings Concall dated Nov. 06, 2021. Corporate Participants: M. Satish Choudhury -- Company Secretary & Compliance Officer